Content about Auditing

February 28, 2014

Mead Johnson Nutrition on Friday expanded the size of its board from 11 to 12 members and appointed Michael Grobstein as its newest director.

GLENVIEW, Ill. — Mead Johnson Nutrition on Friday expanded the size of its board from 11 to 12 members and appointed Michael Grobstein as its newest director. He is a retired vice chairman of Ernst & Young, one of the world's largest professional services organizations.

November 21, 2012

Each year, we say goodbye to the current year and welcome in the New Year full of hope and aspirations for a successful year ahead. Customers turn out in droves for “New Year, New You” specials and when they reach the register, the retail pharmacy world knows the scenario quite well.

Each year, we say good-bye to the current year and welcome in the New Year full of hope and aspirations for a successful year ahead. Customers turn out in droves for “New Year, New You” specials and when they reach the register, the retail pharmacy world knows the scenario quite well. In a few short weeks’ time, you and your staff will be asking these all too familiar questions, “Did you have any insurance changes? Did you have a change in benefits?  Did you know your brand drug is now available in generic?” and so on.

September 25, 2012

There is no doubt about it. Pharmacy audits can be time consuming and laborious for all parties involved. And as both government and commercial money gets tighter and tighter, all of health care is searching for the most effective means to manage the financial challenges associated with doing business. In addition to the clinical aspects, audits are used to identify genuinely fraudulent or erroneously paid healthcare claims. Nevertheless, a survey released in September 2012 by the National Community Pharmacists Association found that nearly 87% of those surveyed stated that reimbursement and auditing practices are “significantly” or “very significantly” affecting their ability to provide patient care and remain in business.

There is no doubt about it. Pharmacy audits can be time consuming and laborious for all parties involved. And as both government and commercial money gets tighter and tighter, all of health care is searching for the most effective means to manage the financial challenges associated with doing business. In addition to the clinical aspects, audits are used to identify genuinely fraudulent or erroneously paid healthcare claims.

June 21, 2012

Legislation proposed in the House of Representatives would speed up Food and Drug Administration approval of knock-off versions of vaccines and other biologics while requiring the agency to conduct more inspections of drug factories overseas, according to published reports.

WASHINGTON — Legislation proposed in the House of Representatives would speed up Food and Drug Administration approval of knock-off versions of vaccines and other biologics while requiring the agency to conduct more inspections of drug factories overseas, according to published reports.

April 27, 2012

The National Association of Chain Drug Stores has expressed its support for enactment of the Pharmacy Audit Integrity Program, a law that will establish standards in the pharmacy audit process conducted by pharmacy benefit management companies in the state of Minnesota.

ALEXANDRIA, Va. — The National Association of Chain Drug Stores has expressed its support for enactment of the Pharmacy Audit Integrity Program (HF 1236/SF 973) by Minnesota governor Mark Dayton. The law will establish standards in the pharmacy audit process conducted by pharmacy benefit management companies in the state of Minnesota.

NACDS sent a letter of support to Dayton prior to enactment, emphasizing the importance of this legislation in ensuring transparency in the PBM audit process.
 

April 11, 2012

Walgreens on Tuesday evening elected Jan Babiak, a retired managing partner for Ernst & Young, to its board of directors.

DEERFIELD, Ill. — Walgreens on Tuesday evening elected Jan Babiak, a retired managing partner for Ernst & Young, to its board of directors. Babiak, who joins the board as an independent director, becomes the board’s 12th member.

February 21, 2010

Alexza Pharmaceuticals has promoted controller and director Mark Oki to controller and VP finance, the...